CERo Therapeutics Holdings, Inc. Common Stock

NASDAQ:CERO USA Biotechnology

Market Cap

$738.59K

Market Cap Rank

#36717 Global

#11947 in USA

Share Price

$0.04

Change (1 day)

+0.00%

52-Week Range

$0.03 - $19.83

All Time High

$19.83

CERo Therapeutics Holdings, Inc. Common Stock - Asset Resilience Ratio

Latest as of June 2025: 8.06%

CERo Therapeutics Holdings, Inc. Common Stock (CERO) has an Asset Resilience Ratio of 8.06% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$500.00K

Cash + Short-term Investments

Total Assets

$6.20 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how CERo Therapeutics Holdings, Inc. Common Stock's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down CERo Therapeutics Holdings, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$500.00K	8.06%
Total Liquid Assets	$500.00K	8.06%

Asset Resilience Insights

Limited Liquidity: CERo Therapeutics Holdings, Inc. Common Stock maintains only 8.06% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.